AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Ostial Corporation to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The Flash Ostial System is designed to help overcome the challenges of aorto-ostial stenting and compliments the Mynx® Product Family of Vascular Closure Devices to expand AccessClosure’s portfolio.

The Cardiovascular Care Group (TCVCG), announced today it has united with The Vein Institute of New Jersey to offer patients access to an expanded team of highly skilled clinicians with outstanding results and additional locations throughout Central and Northern New  Jersey. Reinforcing its commitment to producing great outcomes for the millions of Americans who have varicose and spider veins, the merger increases the number of board–certified physicians available to patients further enabling The Vein Institute at TCVCG to meet the growing demand for its services.

Data from a study led by researchers at Saint Luke's Mid America Heart Institute<http://globalmessaging1.prnewswire.com/clickthrough/servlet/clickthrough?msg_id=7563978&adr_order=59&url=aHR0cDovL3d3dy5zYWludGx1a2VzaGVhbHRoc3lzdGVtLm9yZy9zZXJ2aWNlcy9oZWFydC1hbmQt%0AdmFzY3VsYXItY2FyZGlvdmFzY3VsYXItc2VydmljZXM%3D> showed marked, long-term improvement in health status in patients suffering from peripheral artery disease treated with the S.M.A.R.T. Nitinol Self-Expandable Stent. The study was sponsored by Cordis Corporation, (Fremont, Calif.), manufacturer of the S.M.A.R.T. Stent.

Faced with a disparate array of information technology (IT) products throughout its 19 facilities located in the state of Virginia, Sentara Healthcare selected Medstreaming Vascular Software Solutions and began an enterprise-wide installation late last year. Post-installation, Sentara officials have reported significant efficiency gains in patient throughput, report standardization, quality and workflow.

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the CE Mark approval of its next-generation EnligHTN&trade; Renal Denervation System for treating patients with drug-resistant, uncontrolled hypertension. The system features an advanced generator that delivers simultaneous ablations via a multi-electrode catheter, reducing total ablation time with the new EnligHTN system by more than 80 percent in comparison to the first generation system, from approximately 24 minutes to four minutes. The EnligHTN system will be on display during the 2013 European Society of Cardiology (ESC) meeting from August 31 to September 3.

The Spectranetics Corporation (Nasdaq:SPNC), a leading maker of medical devices used in minimally invasive cardiovascular procedures, today announced the appointment of Kimberly McIntosh Bridges as Senior Vice President, Sales and Marketing, Vascular Intervention, effective August 30, 2013. She will report to Scott Drake, President and Chief Executive Officer, and will be located at the company&#39;s global headquarters in Colorado Springs, CO.

For millions of Americans, simply walking to the mailbox can cause unbearable leg pain as muscles scream for more blood and oxygen.

Southampton Hospital hosted a ground-breaking ceremony on August 12, 2013 to celebrate the beginning of its new Audrey and Martin Gruss Heart and Stroke Center and to honor the Gruss&rsquo; extraordinary gift of $5 million to the new facility at the Hospital.&nbsp; When completed, the Center will provide stroke treatment and carotid stents as needed and will consolidate a broad spectrum of new and sophisticated diagnostic and treatment capabilities with existing cardiovascular programs and services.&nbsp;